The cancer chemotherapeutic 5-fluorouracil is a potent inhibitor of Fusobacterium nucleatum and its activity is modified by the intratumoral microbiota
K. D. LaCourse, A. Baryiames, A. G. Kempchinsky, C. D. Johnston, S. Bullman
This study identifies 5-fluorouracil as a potent inhibitor of Fusobacterium nucleatum in colorectal cancer and shows that intratumoral microbiota can modify its activity.
bioRxiv · Mar 12, 2022Microbiology